Antidote for Pradaxa Bleeds May Impact Sales of Xarleto
The makers of Pradaxa are asking the FDA to approve a reversal agent that could help doctors alleviate uncontrollable bleeding events linked to the blood thinner.
The makers of Pradaxa are asking the FDA to approve a reversal agent that could help doctors alleviate uncontrollable bleeding events linked to the blood thinner.